Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04542421 · ClinicalTrials.gov registry record · NA

Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19

A NA study of COVID-19, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
384
Enrollment target
1
Study location

NCT04542421: Completed NA study of COVID-19, sponsored by University of Colorado, Denver.

NCT04542421 is a NA study of COVID-19 that has completed, run by University of Colorado, Denver. The registered enrollment target is 384 participants, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04542421, a NA study of COVID-19, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
384 participants
Enrollment target
1
Study location

Study Summary

Lung ultrasound (LUS) has also been shown to be more accurate than chest x-ray in identifying pulmonary consolidation and pulmonary edema, both of which are found in patients with COVID. The investigators hypothesize implementation of LUS by hospitalists in the management of suspected or diagnosed patients with COVID-19 will reduce the need for Chest CT and chest x-ray, thereby conserving PPE, reducing risk of transmission to technicians and conserving the resources of radiology services that would otherwise be overwhelmed by patients with COVID-19 in need of chest imaging. Using the methods of implementation science, the investigators propose to respond to the urgent need for rapid implementation of LUS by hospitalists in management of adult patients hospitalized for COVID. Aim 1a: Using a rapid-cycle weekly Plan-Do-Study-Act cycle and Rapid Iterative RE-AIM, to optimize the implementation of LUS by adult hospitalists in the management of COVID-19 patients in a pilot study Aim 1b: Evaluate this pilot implementation of LUS by adult hospitalists using the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework.

Primary Outcome

Number of hospitalists who adopt lung ultrasound in the care of patients hospitalized with COVID

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Lung ultrasound use in patients hospitalized with COVID

Study Locations (1)

Colorado

  • University of Colorado - Denver

Trial Details

FieldValue
Enrollment Target 384 participants
Start Date 2020-07-01
Est. Completion 2022-02-01
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT04542421 record still lists

NCT04542421 is an interventional study that assigns participants to a tested intervention. The registered 384 participants enrollment target is mid-sized for trials with a published cap, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower).

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Lung ultrasound use in patients hospitalized with COVID is the first listed.

NCT04542421 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT04542421 about?

NCT04542421 is a clinical study titled "Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19". Lung ultrasound (LUS) has also been shown to be more accurate than chest x-ray in identifying pulmonary consolidation and pulmonary edema, both of which are found in patients with COVID. The investigators hypothesize implementation of LUS by hospitalists in the management of suspected or diagnosed ...

What is the current status of trial NCT04542421?

This trial is currently completed. It is a NA study. The enrollment target is 384 participants. The study started on 2020-07-01. Estimated completion is 2022-02-01.

What conditions does trial NCT04542421 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT04542421?

The interventions under investigation include: Lung ultrasound use in patients hospitalized with COVID (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04542421?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04542421 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04542421's enrollment target sits among peer trials

384 126th of 298 higher than 173 of 298 other COVID-19 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06277661 · 384 participants · NA

    The Mom and Infant Outcomes (MOMI) Study

  • NCT06372964 · 384 participants · Phase 3

    Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

  • NCT06501040 · 384 participants · NA

    Increasing Knowledge and Interest in Cancer Clinical Trials

  • NCT06566703 · 384 participants · NA

    Testing ANSOS for Efficacy in Multi-Tribal Urban Communities

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04542421, the US trial registry maintained by the National Library of Medicine. NCT04542421 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.